Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
Sign Up to like & getrecommendations! Published in 2022 at "Dose-Response"
DOI: 10.1177/15593258221105370
Abstract: Objective To evaluate the clinical efficacy and safety of baricitinib, a Janus kinase (JAK) inhibitor, in treating patient with progressing vitiligo, and to further explore the regulation of baricitinib on melanocytes (MCs) in vitro. Methods… read more here.
Keywords: treating progressing; baricitinib; baricitinib effective; tyrosinase activity ... See more keywords